Expanding our Ability to Learn from Data
Enhancing Privacy, Security, and Transparency
Breaking Silos to Access and Enrich Data for Discovery
LunaDNA, founded by Luna Public Benefit Corporation (LunaPBC) is a community-owned platform for health research. Anyone can join, share their health data, and receive ownership shares in the company. When researchers conduct studies on the data in our secure platform, the proceeds are passed back to the community as dividends.
LunaDNA was created by LunaPBC, a team of passionate genomics and technology veterans. LunaPBC is responsible for managing the LunaDNA platform, including developing research projects with non-profits and for-profits to make medical discoveries with the health data on the platform.
The LunaPBC team holds integrity, honesty, and transparency as top values. We are passionate about science, technology, and the promise they hold for medicine.
Purpose Driven
Inspired by life experiences to improve health and quality of life for everyone
People First
Sharing a deep-rooted desire to solve important problems for the greater good of humanity
High Integrity
Creating an opportunity for all stakeholders by establishing a community based on understanding, authenticity, honesty, and transparency
Inclusive Innovation
Making a people-centered platform that reflects the diversity seen all over the world
Dawn Barry
President + Co-founder
Dawn served as the Vice President of Applied Genomics at Illumina, Inc. Dawn integrated market development strategies with product and business model innovation to accelerate the application of genomics in medicine and personal healthcare. Dawn joined Illumina in 2005.
Prior to Illumina, Dawn spent seven years at Genaissance Pharmaceuticals, one of the first genomics startups focused on individualized medicine and DNA-based diagnostic testing.
She holds a BS in biology from the University of Vermont and a MBA from the University of Connecticut School of Business.
Bob Kain
CEO + Co-founder
Bob Kain is a renowned pioneer in genomics. At Illumina, Bob led the invention of the modern, high throughput genome sequencer that brought the cost from millions of dollars down to less than $1000.
He joined Illumina pre-IPO in 1999 and retired in 2014, as the Chief Engineering Officer. Bob is lead inventor on 28 U.S. patents that led to the breakthroughs that have revolutionized genome sequencing. Prior to joining Illumina, Bob was the Director of the Microarray Business Unit at Molecular Dynamics. He is also on the Scientific Advisory Boards of Dovetail Genomics, Singular Genomics, and Edenroc Biosecurity, and is the co-founder of Revere Biosensor. Additionally, he is the co-founder and chairman of the board of a successful health & fitness business, Mesa Rim Climbing and Fitness Center, with multiple locations in San Diego and Reno, Nevada.
Bob received a BS in Physics from San Diego State University and an MBA from Saint Mary’s College of California.
David Lewis
CFO + Co-founder
Chief Investment Officer & Co-Founder at Ganley Investments, Former Citigroup Executive
Scott Kahn, Ph.D
Chief Information and Privacy Officer
Former CIO and VP of Commercial and Enterprise Informatics at Illumina
Kirby Bloom
CTO
Former Head of Software + Informatics, Applied Genomics at Illumina
Debora Thompson
VP of Strategy + Business Operations
Former Director of Market Strategy and Innovation, Clinical Genomics at Illumina
Bojil Velinov
Head of Dev Ops + Automation
Former Sr. Dev Ops Architect, Clinical Genomics at Illumina
James White
VP of Member Engagement + Experience
Genevieve Lopez
Head of Digital Engagement
Mike Fennessy
Creative Director
Alexandra Leonidova
Software Engineer
Thomas Rodriguez
Software Engineer
Sanjay John
Software Engineer
Representing seasoned healthcare and patient advocates, data scientists, and consumer engagement leaders, our advisory board exemplifies the expertise needed to help build a member-centric, future-focused Public Benefit Corporation.
David Barker, Ph.D
Advisor, Former Chief Scientific Officer of Illumina
Carlos Bustamante, Ph.D
Advisor, Professor of Biomedical Data Science and Genetics at Stanford University
Christian Cabou
Advisor, Former SVP & General Counsel of Illumina, Inc.
Alex Casdin
Advisor, Founder & CEO of Reneo Capital healthcare fund; former VP Amylin Pharmaceuticals
Tshaka Cunningham, Ph.D.
Advisor, Co-Founder & Chief Scientific Officer of Trugenomix, Executive Director of FBGRI
Jason Paragas
Advisor, Former Director of Innovation at Lawrence Livermore National Laboratory, Former Associate Director for Science at NIH
Josh Shapiro, PhD
Advisor, Assistant Dean of Innovation and Research Affairs at University of California San Diego
Sharon Terry
Advisor, CEO at Genetic Alliance, Chair of the Coalition for Genetic Fairness
Ashley Van Zeeland, Ph.D
Advisor, VP, Product Development Business Operations & Systems Integration at Illumina, Former CTO at Human Longevity, Former Co-Founder Cypher Genomics
Ed Yu
Advisor, Chairman of Vascular Cures, Former partner at PwC Strategy & Healthcare
LunaPBC is backed by leading healthcare and technology investors including:
Arch Venture Partners
Biotech VC Fund
Bain
Future-Tech VC Fund
David Walt
Harvard Medical School
F-Prime
Future-Tech VC Fund
Illumina Ventures
Biotech VC Fund
OUP
Future-Tech VC Fund